XML 28 R17.htm IDEA: XBRL DOCUMENT v3.25.3
Note 11 - Stock-based Compensation
9 Months Ended
Sep. 28, 2025
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

Note 11 — Stock-Based Compensation

 

Stock-based compensation expense from continuing operations included in the Company's unaudited condensed consolidated financial statements for the three and nine months ended September 28, 2025 and September 29, 2024 was as follows (in thousands):

  

Three Months Ended

  

Nine Months Ended

 
  

September 28, 2025

  

September 29, 2024

  

September 28, 2025

  

September 29, 2024

 

Cost of revenue

 $231  $237  $578  $675 

Research and development

  96   428   443   729 

Selling, general and administrative

  501   645   1,586   2,131 

Total

 $828  $1,310  $2,607  $3,535 

 

The Company capitalized certain stock-based compensation amounts to capitalized internal-use software and tooling, net related to continuing operations of $13 thousand and $41 thousand for the three and nine months ended September 28, 2025, respectively, and $12 thousand and $42 thousand for the three and nine months ended September 29, 2024, respectively. The capitalized stock-based compensation amounts relate to compensation for employees involved in the development of capitalized internal-use software and tooling.

 

Stock-Based Compensation Award Activity

 

The following table summarizes the activity in the shares available for grant under the 2019 Plan during the nine months ended September 28, 2025 (in thousands):

 

  

Shares Available for Grants

 

Balance at December 29, 2024

  65 

Authorized

  1,100 

PSUs/RSUs granted

  (618)

PSUs/RSUs forfeited or expired

  36 

Balance at September 28, 2025

  583 

 

Stock Options

 

The following table summarizes stock options outstanding and stock option activity under the 2009 Plan and the 2019 Plan, and the related weighted average exercise price for the nine months ended September 28, 2025:

 

      

Weighted

  

Weighted

     
      

Average

  

Average

  

Aggregate

 
  

Number of

  

Exercise

  

Remaining

  

Intrinsic

 
  

Shares

  

Price

  

Term

  

Value

 
  

(in thousands)

      

(in years)

  

(in thousands)

 

Balance outstanding at December 29, 2024

  48  $12.05         

Forfeited or expired

    $         

Balance outstanding, exercisable, and vested at September 28, 2025

  48  $12.05   0.94  $ 

 

No stock options were granted or exercised during the nine months ended September 28, 2025 and September 29, 2024. No stock options expired during the nine months ended September 28, 2025. Stock options equivalent to 6 thousand shares expired during the nine months ended September 29, 2024.

 

Total stock-based compensation related to stock options was $0 during the nine months ended September 28, 2025 and September 29, 2024.

 

Restricted Stock Units

 

The Company grants restricted stock units (“RSUs”) and performance restricted stock units ("PRSUs") to employees and directors with various vesting terms. RSUs entitle the holder to receive, at no cost, one common share for each RSU as it vests. In general, the Company's policy is to withhold shares in settlement of employee tax withholding obligations upon the vesting of RSUs. The stock-based compensation expense in continuing operations related to RSUs and PRSUs were approximately $0.8 million and $2.5 million for the three and nine months ended September 28, 2025, respectively and approximately $1.2 million and $3.5 million for the three and nine months ended September 29, 2024, respectively.

 

As of  September 28, 2025 and September 29, 2024, there was approximately $3.6 million and $3.8 million, respectively, in unrecognized stock-based compensation expense related to RSUs. The remaining unrecognized stock-based compensation expense as of September 28, 2025 is expected to be recorded over a weighted average period of 1.68 years.

 

A summary of activity for the Company's RSUs and PRSUs for the nine months ended September 28, 2025 is as follows:

  

RSUs & PRSUs Outstanding

 
      

Weighted

 
      

Average

 
  

Number of

  

Grant Date

 
  

Shares

  

Fair Value

 
  

(in thousands)

     

Nonvested at December 29, 2024

  599  $7.97 

Granted

  618   5.01 

Vested and released

  (419)  7.64 

Forfeited

  (36)  8.65 

Nonvested at September 28, 2025

  762  $5.72 

 

Employee Stock Purchase Plan

 

Total stock-based compensation in continuing operations related to the Company's Employee Stock Purchase Plan was approximately $51 thousand and $111 thousand for the three and nine months ended September 28, 2025, respectively and approximately $32 thousand and $71 thousand for the three and nine months ended September 29, 2024, respectively.